Clinical Trial Update: An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating intravenous L059 in Japanese patients with epilepsy and partial onset seizures completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• L059

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Partial Onset Seizures | Phase 2 | Status: COMPLETED | Results posted: 2013-03-07